Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print


Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com


Buscar en contenido


martes, 11 de junio de 2013

Manejo de anticoagulación: cirugía y procedimientos invasivos

(Review, NEJM) - PulmCCM June 07, 2013

"NOTE: This is a summary of an article in a medical journal, provided as a service to physicians. It is not medical advice. No one should never make changes to their anticoagulation treatment except under a physician’s supervision. Please read the Terms of Use before proceeding.
One in 50 people in the U.S. are taking long-term anticoagulation therapy for a condition like atrial fibrillation, a mechanical heart valve, or a clotting disorder resulting in DVT / PE. Millions more with coronary artery disease or strokes are taking antiplatelets drug like Plavix, and often aspirin as well. About 1 in 10 people on anticoagulation therapy undergo surgery or an invasive procedure each year, and the management of their anticoagulation medicines can be challenging: the physician is expected to simultaneously prevent serious bleeding during the surgery, and also clotting resulting in pulmonary embolism, heart attack, or embolic stroke. Tricky!"

También te podría interesar:
  1. Corrección de anticoagulación excesiva
  2. Dabigatran (Pradaxa®)
  3. Manejo de la anticoagulación
  4. Rivaroxaban (Xarelto)
  5. Trauma craneal en pacientes anticoagulados